PTH and osteoporosis: On the contrary to the effects of PTH, aging affects both bone formation and resorption whose overall effect is an anti-osteoanabolic effect due to the weaker effects on formation.66–68 Thus, we validated the potential therapeutic effects of PCLAF-neutralizing antibody in age-related bone loss, which offered a new strategy for the exploration of anti-osteoporosis drugs.